Cocrystal Pharma DEF 14A: Executive Compensation Details
Ticker: COCP · Form: DEF 14A · Filed: May 5, 2025 · CIK: 1412486
| Field | Detail |
|---|---|
| Company | Cocrystal Pharma, INC. (COCP) |
| Form Type | DEF 14A |
| Filed Date | May 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, DEF14A, corporate-governance
Related Tickers: COCP
TL;DR
Cocrystal Pharma DEF 14A out: exec comp details for 2024, 2023, 2022. See Martin & Lee awards.
AI Summary
Cocrystal Pharma, Inc. filed a DEF 14A on May 5, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on awards granted to members such as James Martin and Sam Lee, and their associated fair values and changes in fair value. It also covers compensation details for the fiscal years 2023 and 2022.
Why It Matters
This filing provides transparency into how Cocrystal Pharma compensates its top executives, which can influence investor decisions and perceptions of company management.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but the specifics of executive compensation can sometimes reveal underlying company performance or strategic shifts.
Key Players & Entities
- Cocrystal Pharma, Inc. (company) — Filer of the DEF 14A
- James Martin (person) — Executive compensation recipient
- Sam Lee (person) — Executive compensation recipient
- BIOZONE PHARMACEUTICALS, INC. (company) — Former name of Cocrystal Pharma
- International Surf Resorts, Inc. (company) — Former name of Cocrystal Pharma
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose of this DEF 14A filing is to provide detailed information regarding the executive compensation of Cocrystal Pharma, Inc. for the fiscal years ending December 31, 2024, 2023, and 2022.
Who are the named individuals whose compensation is detailed in the filing?
The filing details compensation for individuals such as James Martin and Sam Lee, identified as members receiving awards.
What fiscal years does this filing cover for executive compensation?
This filing covers executive compensation for the fiscal years ending December 31, 2024, 2023, and 2022.
What were Cocrystal Pharma's former names?
Cocrystal Pharma, Inc. was formerly known as BIOZONE PHARMACEUTICALS, INC. (name change on 20110304) and prior to that, International Surf Resorts, Inc. (name change on 20070917).
What is the business address and phone number for Cocrystal Pharma, Inc.?
The business address for Cocrystal Pharma, Inc. is 19805 N. CREEK PARKWAY, BOTHELL, WA 98011, and the business phone number is (786) 459-1831.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 5, 2025 by James Martin regarding Cocrystal Pharma, Inc. (COCP).